Krystal Biotech Inc (KRYS)

SG&A Expenses

$39.85M

Quarterly · Period ending: · USD

KRYS logo

KRYS SG&A Expenses

Latest reported$39.85M
KRYS Quarterly SG&A Expenses ($81.00K → $39.85M)
High-resolution chart · PNG

KRYS sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Krystal Biotech Inc SG&A Expenses — Quarterly (USD)
Period endingSG&A Expenses (USD)
39,850,000
41,014,000
41,280,000
37,578,000
35,160,000
32,723,000
31,288,000
28,713,000
27,626,000
26,058,000
23,257,000
23,697,000
25,904,000
24,035,000
24,030,000
19,935,000
17,863,000
15,355,000
12,867,000
9,572,000
9,799,000
8,152,000
4,748,000
4,580,000
3,315,000
2,421,000
1,805,000
1,457,000
1,674,000
1,527,000
1,417,000
1,058,000
924,000
757,000
410,000
738,000
269,000
146,000
218,000
81,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.